Overexpression of miR-34a in EGFR mutant NSCLC increased sensitivity to gefitinib, resulting in increased inhibition of cell growth and to induced apoptosis, which resulted in tumor regression. This evidence concerns the gene EGFR and non-small cell lung carcinoma.